{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:02:35Z","timestamp":1769205755858,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013117","name":"Mundipharma Deutschland GmbH & Co. KG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013117","name":"Mundipharma Deutschland GmbH & Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jphs.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T02:22:35Z","timestamp":1591928555000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care"],"prefix":"10.1016","volume":"144","author":[{"given":"Cinzia","family":"Baschirotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Verthein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2020.06.004_bib1","series-title":"World drug report 2018","year":"2018"},{"key":"10.1016\/j.jphs.2020.06.004_bib2","series-title":"World drug report 2000","year":"2000"},{"key":"10.1016\/j.jphs.2020.06.004_bib3","series-title":"European drug report. Trends and developments. Luxembourg","year":"2018"},{"key":"10.1016\/j.jphs.2020.06.004_bib4","series-title":"United Nations office on drugs and crime, joint United Nations programme on HIV\/AIDS. Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention: position paper","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.jphs.2020.06.004_bib5","series-title":"European drug report","year":"2013"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"J\u00a0Addict Dis"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.004_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harv Rev Psychiatr"},{"issue":"1\u20132","key":"10.1016\/j.jphs.2020.06.004_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jphs.2020.06.004_bib9","first-page":"CD004145","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","volume":"8","author":"Gowing","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","article-title":"Mortality in heroin addiction: impact of methadone treatment","volume":"82","author":"Gronbladh","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jphs.2020.06.004_bib11","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jphs.2020.06.004_bib12","article-title":"Methods of detoxification and their role in treating patients with opioid dependence","volume":"294","author":"O'Connor","year":"2005","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/15622975.2011.561872","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: opioid dependence","volume":"12","author":"Soyka","year":"2011","journal-title":"World J Biol Psychiatr: Off J World Federation Soc Biolo. Psychiatr."},{"issue":"6","key":"10.1016\/j.jphs.2020.06.004_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1360-0443.1997.tb02937.x","article-title":"Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment","volume":"92","author":"Torrens","year":"1997","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.jphs.2020.06.004_bib15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1360-0443.2005.01089.x","article-title":"Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain","volume":"100","author":"Brugal","year":"2005","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.jphs.2020.06.004_bib16","doi-asserted-by":"crossref","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technol Assess"},{"issue":"3 Suppl","key":"10.1016\/j.jphs.2020.06.004_bib17","article-title":"Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results","volume":"153","author":"Lavignasse","year":"2002","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.jphs.2020.06.004_bib18","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"3","author":"Mattick","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.jphs.2020.06.004_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid DependenceA randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09595239400185431","article-title":"The effectiveness of methadone maintenance treatment: an overview","volume":"13","author":"Ward","year":"1994","journal-title":"Drug Alcohol Rev"},{"issue":"11","key":"10.1016\/j.jphs.2020.06.004_bib21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1360-0443.1997.tb02866.x","article-title":"Patterns of symptom complaints in methadone maintenance patients","volume":"92","author":"Dyer","year":"1997","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.004_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1973.03220060039009","article-title":"Medical safety and side effects of methadone in tolerant individuals","volume":"223","author":"Kreek","year":"1973","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1517\/14740338.6.3.289","article-title":"Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology","volume":"6","author":"Ehret","year":"2007","journal-title":"Expet Opin Drug Saf"},{"issue":"12","key":"10.1016\/j.jphs.2020.06.004_bib24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors","volume":"166","author":"Ehret","year":"2006","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.jphs.2020.06.004_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jphs.2020.06.004_bib26","first-page":"1381","article-title":"Drug interactions with methadone","volume":"28","author":"Schlatter","year":"1999","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.004_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cpt1978232175","article-title":"Methadone maintenance: plasma levels and therapeutic outcome","volume":"23","author":"Holmstrand","year":"1978","journal-title":"Clin Pharmacol Therapeut"},{"issue":"10","key":"10.1016\/j.jphs.2020.06.004_bib28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1176\/ajp.144.10.1349","article-title":"Inadequate plasma concentrations in some high-dose methadone maintenance patients","volume":"144","author":"Tennant","year":"1987","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.jphs.2020.06.004_bib29","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"World Health Organization","year":"2009"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.004_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1360-0443.1999.9422317.x","article-title":"Comparison of methadone and slow-release morphine maintenance in pregnant addicts","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib31","first-page":"30","article-title":"High dose buprenorphine may be an effective interim treatment for long term heroin users waiting for drug-assisted rehabilitation","volume":"6","author":"Clark","year":"2003","journal-title":"Evid Base Ment Health"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000085550","article-title":"Use of slow-release oral morphine for the treatment of opioid dependence","volume":"11","author":"Kraigher","year":"2005","journal-title":"Eur Addiction Res"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.004_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: a systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"J\u00a0Addict Dis"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.004_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.8.1.1","article-title":"Opioid maintenance: a comparative review of pharmacological strategies","volume":"8","author":"White","year":"2007","journal-title":"Expet Opin Pharmacother"},{"issue":"12","key":"10.1016\/j.jphs.2020.06.004_bib35","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1360-0443.2005.01286.x","article-title":"New horizons: sustained release morphine as agonist treatment","volume":"100","author":"Woody","year":"2005","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.jphs.2020.06.004_bib36","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1360-0443.2005.001128.x","article-title":"Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy","volume":"100","author":"Eder","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.004_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7326\/M17-2373","article-title":"Evaluating slow-release oral morphine to narrow the treatment gap for opioid use disorders","volume":"168","author":"Soc\u00edas","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jphs.2020.06.004_bib38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2165\/00044011-199713030-00006","article-title":"Comparative single-dose phannacokinetics of sustained-release and modified-release morphine sulfate capsules under fed and fasting conditions","volume":"13","author":"Broomhead","year":"1997","journal-title":"Clin Drug Invest"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.004_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpainsymman.2004.04.015","article-title":"Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain","volume":"29","author":"Hagen","year":"2005","journal-title":"J\u00a0Pain Symptom Manag"},{"key":"10.1016\/j.jphs.2020.06.004_bib40","first-page":"133","article-title":"Opioid pharmacology. Pain physician","volume":"11","author":"Trescot","year":"2008","journal-title":"Opioid Special Issue"},{"issue":"1","key":"10.1016\/j.jphs.2020.06.004_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(03)00190-X","article-title":"Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence","volume":"72","author":"Mitchell","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.004_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/add.12440","article-title":"Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone","volume":"109","author":"Beck","year":"2014","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.004_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000368572","article-title":"Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study","volume":"21","author":"Verthein","year":"2015","journal-title":"Eur Addiction Res"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.004_bib44","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1465-3362.2011.00353.x","article-title":"After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication","volume":"31","author":"Bond","year":"2012","journal-title":"Drug Alcohol Rev"},{"issue":"11","key":"10.1016\/j.jphs.2020.06.004_bib45","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/j.1360-0443.2008.02334.x","article-title":"Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression","volume":"103","author":"Kastelic","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.jphs.2020.06.004_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-0030-1270518","article-title":"[The usefulness of the Brief Symptom Inventory 18 (BSI-18) in psychotherapeutic patients]","volume":"61","author":"Franke","year":"2011","journal-title":"Psychother Psych Med"},{"key":"10.1016\/j.jphs.2020.06.004_bib47","series-title":"[Prescribing information Substitol\u00ae 30\/60\/100\/200 mg hard capsules, retarded]","year":"2018"},{"issue":"4","key":"10.1016\/j.jphs.2020.06.004_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jsat.2014.05.012","article-title":"Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence","volume":"47","author":"H\u00e4mmig","year":"2014","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.jphs.2020.06.004_bib49","first-page":"36","article-title":"[Addiction medicine in research and practice]","volume":"4","author":"Haltmayer","year":"2010","journal-title":"\u00d6\u00c4Z."},{"issue":"1","key":"10.1016\/j.jphs.2020.06.004_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13011-018-0187-9","article-title":"Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: a cross-sectional study","volume":"14","author":"Strada","year":"2019","journal-title":"Subst Abuse Treat Prev Pol"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.004_bib51","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/JCP.0000000000000288","article-title":"Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial","volume":"35","author":"Falcato","year":"2015","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jphs.2020.06.004_bib52","series-title":"Statistical Bulletin 2018 - drug-related infectious diseases: infectious diseases > Notifications > HCV","year":"2018"},{"issue":"9791","key":"10.1016\/j.jphs.2020.06.004_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jphs.2020.06.004_bib54","series-title":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte. [Report on the Substitution Register]","year":"2018"},{"issue":"8","key":"10.1016\/j.jphs.2020.06.004_bib55","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jphs.2020.06.004_bib56","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)38234-5","article-title":"D-methadone blocks morphine tolerance and N-Methyl-DAspartate-Induced hyperalgesia","volume":"289","author":"Davis","year":"1999","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jphs.2020.06.004_bib57","series-title":"European monitoring Centre for drugs and drug addiction (EMCDDA)","year":"2019"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:00:02Z","timestamp":1761163202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861320300608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1347861320300608"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2020.06.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}